Fig. 3From: Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patientsProbability of target attainment for a 300-mg intermittent intravenous infusion (90 min) of posaconazole given every 8 h for simulated patients with fixed BMI of 24 kg/m2 and varying albumin level considering total (a) and unbound (b) trough concentration targetsBack to article page